Literature DB >> 11553418

Glioma models.

C Dai1, E C Holland.   

Abstract

Gliomas are primary central nervous system tumors that arise from astrocytes, oligodendrocytes or their precursors. Gliomas can be classified into several groups according to their histologic characteristics, the most malignant of the gliomas is glioblastoma multiforme. In contrast to the long-standing and well-defined histopathology, the underlying molecular and genetic bases for gliomas are only just emerging. Many genetic alterations have been identified in human gliomas, however, establishing unequivocal correlation between these genetic alterations and gliomagenesis requires accurate animal models for this disease. Here we are reviewing the existing animal models for gliomas with different strategies and our current knowledge on the important issues about this disease, such as activation of signal transduction pathways, disruption of cell cycle arrest pathways, cell-of-origin of gliomas, and therapeutic strategies.

Entities:  

Mesh:

Year:  2001        PMID: 11553418     DOI: 10.1016/s0304-419x(01)00027-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

1.  Modulation of oxidative stress in response to gamma-radiation in human glioma cell lines.

Authors:  Felipe Dal-Pizzol; Cristiane Ritter; Fábio Klamt; Michael Andrades; Mário Luís Conte da Frota; Cléber Diel; Celito de Lima; Aroldo Braga Filho; Gilberto Schwartsmann; José Cláudio Fonseca Moreira
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

2.  Transposon mediated integration of plasmid DNA into the subventricular zone of neonatal mice to generate novel models of glioblastoma.

Authors:  Anda-Alexandra Calinescu; Felipe Javier Núñez; Carl Koschmann; Bradley L Kolb; Pedro R Lowenstein; Maria G Castro
Journal:  J Vis Exp       Date:  2015-02-22       Impact factor: 1.355

3.  Accessing key steps of human tumor progression in vivo by using an avian embryo model.

Authors:  Martin Hagedorn; Sophie Javerzat; Delphine Gilges; Aurélie Meyre; Benjamin de Lafarge; Anne Eichmann; Andreas Bikfalvi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

4.  Inhibition of cystine uptake disrupts the growth of primary brain tumors.

Authors:  Wook Joon Chung; Susan A Lyons; Gina M Nelson; Hashir Hamza; Candece L Gladson; G Yancey Gillespie; Harald Sontheimer
Journal:  J Neurosci       Date:  2005-08-03       Impact factor: 6.167

5.  Volume reconstruction techniques improve the correlation between histological and in vivo tumor volume measurements in mouse models of human gliomas.

Authors:  Karl F Schmidt; Mateo Ziu; Nils Ole Schmidt; Pramil Vaghasia; Theresa G Cargioli; Sameer Doshi; Mitchell S Albert; Peter McL Black; Rona S Carroll; Yanping Sun
Journal:  J Neurooncol       Date:  2004-07       Impact factor: 4.130

6.  Real-time multi-modality imaging of glioblastoma tumor resection and recurrence.

Authors:  Shawn Hingtgen; Jose-Luiz Figueiredo; Christian Farrar; Matthias Duebgen; Jordi Martinez-Quintanilla; Deepak Bhere; Khalid Shah
Journal:  J Neurooncol       Date:  2012-12-16       Impact factor: 4.130

Review 7.  Vertebrate animal models of glioma: understanding the mechanisms and developing new therapies.

Authors:  Leon Chen; Yuqing Zhang; Jingxuan Yang; John P Hagan; Min Li
Journal:  Biochim Biophys Acta       Date:  2013-04-22

8.  Selective distribution of protein kinase A regulatory subunit RII{alpha} in rodent gliomas.

Authors:  Carla Mucignat-Caretta; Andrea Cavaggioni; Marco Redaelli; Manuela Malatesta; Carlo Zancanaro; Antonio Caretta
Journal:  Neuro Oncol       Date:  2008-08-14       Impact factor: 12.300

9.  Tissue pO2 of orthotopic 9L and C6 gliomas and tumor-specific response to radiotherapy and hyperoxygenation.

Authors:  Nadeem Khan; Hongbin Li; Huagang Hou; Jean P Lariviere; David J Gladstone; Eugene Demidenko; Harold M Swartz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-01-10       Impact factor: 7.038

10.  Assessment of the changes in 9L and C6 glioma pO2 by EPR oximetry as a prognostic indicator of differential response to radiotherapy.

Authors:  Huagang Hou; Sriram P Mupparaju; Jean P Lariviere; Sassan Hodge; Jiang Gui; Harold M Swartz; Nadeem Khan
Journal:  Radiat Res       Date:  2013-02-07       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.